# Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)

> **NCT05154123** · PHASE1 · COMPLETED · sponsor: **Atea Pharmaceuticals, Inc.** · enrollment: 29 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Drug: AT-527 + rosuvastatin
- **DRUG:** AT-527 + rosuvastatin

## Key facts

- **NCT ID:** NCT05154123
- **Lead sponsor:** Atea Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-16
- **Primary completion:** 2021-12-23
- **Final completion:** 2021-12-23
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2022-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154123, "Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05154123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*